Precigen (PGEN) EBT Margin (2012 - 2026)

Precigen (PGEN) reported EBT Margin of 34.1% for Q1 2026, up 400415.0% year-over-year from N/an in Q1 2025, and up 93.38% quarter-over-quarter from 514.85% in Q4 2025.

Precigen (PGEN) EBT Margin (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of EBT Margin data on file, last reported at 34.1% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 34.1%, up 400415.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 733.96% (up 291026.0% YoY), and the FY2025 annual result was 2588.18%, up 67368.0% from the prior year.
  • EBT Margin climbed to 34.1% in Q1 2026 per PGEN's latest filing, from 514.85% in the prior quarter.
  • Over five years, EBT Margin peaked at 154.91% in Q4 2022 and troughed at 1980100.0% in Q3 2023.
  • A 5-year average of 131615.27% and a median of 2037.14% in 2024 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2023 and 2024: EBT Margin tumbled 197966034 bps in 2023, then surged 197739503 bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 154.91% in 2022, then tumbled by 1855 bps to 2718.89% in 2023, then surged by 50 bps to 1369.32% in 2024, then jumped by 62 bps to 514.85% in 2025, then surged by 93 bps to 34.1% in 2026.
  • Business Quant data shows PGEN's EBT Margin at 34.1% in Q1 2026, 514.85% in Q4 2025, and 78350.0% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 41.95%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn -34.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.10%
Dec 31, 2025 -514.85%
Jun 30, 2025 -78,350.00%
Mar 31, 2025 -4,038.26%
Dec 31, 2024 -1,369.32%
Sep 30, 2024 -2,704.97%
Jun 30, 2024 -8,986.78%
Mar 31, 2024 -17,222.46%
Dec 31, 2023 -2,718.89%
Sep 30, 2023 -1,980,100.00%
Jun 30, 2023 -1,153.59%
Mar 31, 2023 -7,033.64%
Dec 31, 2022 154.91%
Sep 30, 2022 -439.66%
Jun 30, 2022 -898.25%
Mar 31, 2022 -434.54%
Dec 31, 2021 261.49%
Sep 30, 2021 -791.48%
Jun 30, 2021 -812.56%
Mar 31, 2021 -89.33%